The success of gene therapy depends on…diagnostic testing

In this Knect365 article, David Parker, PhD, Precision’s Senior VP, Diagnostics Solutions, explains why diagnostic tests are of critical importance to both the commercial and therapeutic success of gene therapies—then shares developer’s strategies to combat the reimbursement issues that are creating serious access challenges for such tests. 

Read the article

Precision Medicine Group is an integrated team of experts in fields from advanced lab sciences to translational informatics and regulatory affairs, payer insights to marketing communications. Together, we help our pharmaceutical and life-sciences clients conquer product development and commercialization challenges in a rapidly evolving environment.